Journal of Experimental Stroke and Translational Medicine

Aims & Scope

JESTM provides high quality tailored contents to stroke investigators.

The scope of the journal covers original studies and reviews in experimental stroke and translational medical research.

Special emphases are placed on new concepts and innovative research ideas in neuroprotection for acute ischemic stroke, ischemic attack, stroke rehabilitation and methodological improvements in stroke studies.

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine and Neuroscience, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Clinical trial structures

  Citation: 169

  Authors: Scott R.

• RODENT STROKE MODEL GUIDELINES FOR PRECLINICAL STROKE TRIALS (1ST EDITION)

  Citation: 126

  Authors: Shimin, Gehua, Bruno P., Kym, H Richard

• Targeting ischemic penumbra Part I: from pathophysiology to therapeutic strategy

  Citation: 110

  Authors: Shimin, Steven R., H. Richard

• Fundamentals of clinical trial design

  Citation: 82

  Authors: Scott R.

• A reproducible and simple model of permanent cerebral ischemia in CB-17 and SCID mice

  Citation: 58

  Authors: Akihiko, Yukiko, Takayuki, David M., Mari, Makoto, Tomohiro

• Development of an allogeneic adherent stem cell therapy for treatment of ischemic stroke

  Citation: 34

  Authors: Robert W., Cesar V., Takao, Koichi, Mina, James E., Robert J., David C.

• Targeting ischemic penumbra Part II: selective drug delivery using liposome technologies

  Citation: 21

  Authors: Shimin, Steven R., H. Richard

• Towards a dynamical network view of brain ischemia and reperfusion. Part I: background and preliminaries

  Citation: 16

  Authors: Donald J.

• Long-term survival and serial assessment of stroke damage and recovery – practical and methodological considerations.

  Citation: 13

  Authors: Michel

• Common statistical concerns in clinical trials

  Citation: 11

  Authors: Scott R.